These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 1408152)

  • 41. Sin3 corepressor function in Myc-induced transcription and transformation.
    Harper SE; Qiu Y; Sharp PA
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8536-40. PubMed ID: 8710905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preferential heterodimeric parallel coiled-coil formation by synthetic Max and c-Myc leucine zippers: a description of putative electrostatic interactions responsible for the specificity of heterodimerization.
    Lavigne P; Kondejewski LH; Houston ME; Sönnichsen FD; Lix B; Skyes BD; Hodges RS; Kay CM
    J Mol Biol; 1995 Dec; 254(3):505-20. PubMed ID: 7490766
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oncogenic activity of the c-Myc protein requires dimerization with Max.
    Amati B; Brooks MW; Levy N; Littlewood TD; Evan GI; Land H
    Cell; 1993 Jan; 72(2):233-45. PubMed ID: 8425220
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determination of binding constant of transcription factor myc-max/max-max and E-box DNA: the effect of inhibitors on the binding.
    Park S; Chung S; Kim KM; Jung KC; Park C; Hahm ER; Yang CH
    Biochim Biophys Acta; 2004 Feb; 1670(3):217-28. PubMed ID: 14980448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The leucine zippers of the HLH-LZ proteins Max and c-Myc preferentially form heterodimers.
    Muhle-Goll C; Nilges M; Pastore A
    Biochemistry; 1995 Oct; 34(41):13554-64. PubMed ID: 7577944
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif.
    Hurlin PJ; Steingrìmsson E; Copeland NG; Jenkins NA; Eisenman RN
    EMBO J; 1999 Dec; 18(24):7019-28. PubMed ID: 10601024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of a two-hybrid system to identify mutations in Max that confer increased affinity for Myc.
    Wang H; Van Den Bergh F; Spencer E; Wilcox K; Herman T
    DNA Cell Biol; 1997 Nov; 16(11):1277-88. PubMed ID: 9407000
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improving the thermodynamic stability of the leucine zipper of max increases the stability of its b-HLH-LZ:E-box complex.
    Jean-François N; Frédéric G; Raymund W; Benoit C; Lavigne P
    J Mol Biol; 2003 Mar; 326(5):1577-95. PubMed ID: 12595267
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Small-molecule perturbation of competing interactions between c-Myc and Max.
    Follis AV; Hammoudeh DI; Daab AT; Metallo SJ
    Bioorg Med Chem Lett; 2009 Feb; 19(3):807-10. PubMed ID: 19114306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo.
    James L; Eisenman RN
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10429-34. PubMed ID: 12149476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.
    Blackwood EM; Eisenman RN
    Science; 1991 Mar; 251(4998):1211-7. PubMed ID: 2006410
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Specificity of DNA binding of the c-Myc/Max and ARNT/ARNT dimers at the CACGTG recognition site.
    Swanson HI; Yang JH
    Nucleic Acids Res; 1999 Aug; 27(15):3205-12. PubMed ID: 10454619
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers.
    Maltais L; Montagne M; Bédard M; Tremblay C; Soucek L; Lavigne P
    PLoS One; 2017; 12(3):e0174413. PubMed ID: 28350847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The crystal structure of an intact human Max-DNA complex: new insights into mechanisms of transcriptional control.
    Brownlie P; Ceska T; Lamers M; Romier C; Stier G; Teo H; Suck D
    Structure; 1997 Apr; 5(4):509-20. PubMed ID: 9115440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methods for the expression, purification, preparation, and biophysical characterization of constructs of the c-Myc and Max b-HLH-LZs.
    Beaulieu ME; McDuff FO; Bédard M; Montagne M; Lavigne P
    Methods Mol Biol; 2013; 1012():7-20. PubMed ID: 24006055
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A dominant-negative mutant of Max that inhibits sequence-specific DNA binding by Myc proteins.
    Billaud M; Isselbacher KJ; Bernards R
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2739-43. PubMed ID: 8464883
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reconstitution of an E box-binding Myc:Max complex with recombinant full-length proteins expressed in Escherichia coli.
    Farina A; Faiola F; Martinez E
    Protein Expr Purif; 2004 Apr; 34(2):215-22. PubMed ID: 15003254
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Forced homodimerization of the c-Fos leucine zipper in designed bHLHZ-like hybrid proteins MaxbHLH-Fos and ArntbHLH-Fos.
    Chen G; De Jong AT; Shin JA
    Mol Biosyst; 2012 Apr; 8(4):1286-96. PubMed ID: 22301802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).
    Kyo S; Takakura M; Taira T; Kanaya T; Itoh H; Yutsudo M; Ariga H; Inoue M
    Nucleic Acids Res; 2000 Feb; 28(3):669-77. PubMed ID: 10637317
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo.
    Grandori C; Mac J; Siëbelt F; Ayer DE; Eisenman RN
    EMBO J; 1996 Aug; 15(16):4344-57. PubMed ID: 8861962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.